If youre thinking about improving blood sugar control, working toward weight loss, or both, we at SkinnyRx can help you explore your path forward
A clinician sees every reading Your nurse practitioner reviews your numbers and fine-tunes your plan, so you're never guessing alone
No global settlement has resolved GLP-1 NAION claims at this stage
Present data show, that the dual receptor agonist tirzepatide has exceeded the glucose-lowering and body weight-lowering effects compared to the established GLP-1 RAs (54, 66, 67, 71]
The outcome measure was the incremental cost-effectiveness ratio (ICER), calculated as the ratio of cost differences to QALY differences between different treatments
Furthermore, the high fat content in many fast food items can exacerbate gastrointestinal side effects associated with GLP-1 medications, as noted in FDA Medication Guides